EP2797953
METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.12.2012EP published:
3.6.2020EP application number:
12805890.6
EPO information:
European Patent Register
Max expiry date:
10.12.2032
Title:
METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES
Timeline
Today
11.12.2012EP application
3.6.2020EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Name:
The Regents of the University of MichiganAddress:
1600 Huron Parkway, 2nd Floor, Ann Arbor, MI 48109-2590, US
Inventor
Name:
KE, Hua, ZhuAddress:
Newbury Park, CA 91320, US
Name:
LIU, MinAddress:
Thousand Oaks, CA 91362, US
Name:
GIANNOBILE, William, V.Address:
Ann Arbor, MI 48103, US
Priority
Number:
201161580964 PDate:
28.12.2011Country:
US
Classification
Categories:
C07K 16/22, A61K 39/395, A61P 43/00, A61K 39/00